Fluoropyrimidine-mediated radiosensitization depends on cyclin E- dependent kinase activation

Cancer Research

Volumn 56, Issue 14, 1996, Pages 3203-3206

  Lawrence, Theodore S ^a,b   Davis, Mary A ^a   Loney, Tania L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; FLUOROPYRIMIDINE; THYMIDYLATE SYNTHASE;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; COLON CANCER; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIOSENSITIVITY;

CELL CYCLE; CYCLIN D1; CYCLIN-DEPENDENT KINASES; CYCLINS; DNA, NEOPLASM; ENZYME ACTIVATION; FLOXURIDINE; HUMANS; ONCOGENE PROTEINS; RADIATION-SENSITIZING AGENTS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0029987652     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Pu, T., Robertson, J M., and Lawrence, T S Current status of radiation sensitization by fluorinated pyrimidines. Oncology (Basel), 9: 707-735, 1995.
2. Davis, M. A., Tang, H Y., Maybaum, J., and Lawrence, T S. Dependence of fluorodeoxyuridine-mediated radiosensitization on S Phase progression Int J. Radiat. Biol., 67: 509-512, 1995.
3. Pedrale-Noy, G , and Spadari, S Effect of aphidicolin on viral and human DNA polymerases Biochem. Biophys Res. Commun , 88: 1194-1202, 1979.
4. 1 cyclins. Cell, 73: 1059-1065, 1993
5. Hartwell, L H., and Kastan, M B Cell cycle control and cancer. Science (Washington, DC), 266: 1821-1828, 1994.
6. 1-S phase protein kinase Science (Washington, DC), 257: 1958-1961, 1992.
7. Fornace, A. J Mammalian genes induced by radiation; activation of genes associated with growth control. Annu. Rev Genet., 26: 507-526, 1992.
8. Kastan, M. B., Zhan, Q., El-Deiry, W. S , Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S , Vogelstein, B., and Fornace, A. J A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71: 587-597, 1992.
9. Dulic, V., Kaufmann, W. K., Wilson, S. J., Tisty, T. D., Lees, E., Harper, J. W., Elledge, S. J., and Reed, S. I. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell, 76: 1013-1023, 1994.
10. 1 arrest and apoptosis. Cancer Res., 54: 1169-1174, 1994.
11. Rodrigues, N R , Rowan, A., Smith, M E. F , Kerr, J. B., Bodmer, W. F., Gannon, J. V , and Lane, D. p53 mutations in colorectal cancer. Proc. Natl. Acad. Sci. USA, 87 7555-7559, 1990
12. Hoy, C A., Seamer, L. C , and Schimke, R. T. Thermal denaturation of DNA for immunochemical staining of incorporated bromodeoxyuridine (BrdUrd): critical factors that affect the amount of fluorescence and the shape of BrdUrd/DNA histogram. Cytometry, 10: 718-725, 1989.
13. Kung, A. L , Sherwood, S. W., and Schimke, R. T Differences in the regulation of protein synthesis, cyclin B accumulation, and cellular growth in response to the inhibition of DNA synthesis in Chinese hamster ovary and HeLa S3 cells. J. Biol Chem., 268: 23072-23079, 1993.
14. Maley, F., Pedersen-Lane, J., and Changchien, L-M. Complete restoration of activity to inactive mutants of Escherichia coli thymidylate synthase: evidence the E. coli thymidylate synthase is a half-the-sites activity enzyme. Biochemistry, 34: 1469-1479, 1995.
15. 1 in mammalian fibroblasts Science (Washington DC), 259: 1908-1912, 1993
16. Tishler, R. B., Calderwood, S. K., Coleman, C N., and Price, B. D. Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. Cancer Res., 53 (Suppl): 2212s-2216s, 1993.
17. Fritsche, M., Haessler, C , and Brandner, G. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents Oncogene, 8: 307-318, 1993
18. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51: 6304-6311, 1991.
19. Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., and Kastan, M B. Wild type p53 is a cell cycle check point determinant following irradiation. Proc. Natl. Acad. Sci. USA, 89: 7491-7495, 1992.
20. Zhang, W., Grasso, L , McClain, C. D., Gambel, A. M., Cha, Y., Travali, S., Deisseroth, A. B , and Mercer, W. E. p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/ macrophage differentiation. Cancer Res., 55: 668-674, 1995.
21. Michieli, P , Chedid, M , Lin, D , Pierce, J. H , Mercer, W. E., and Givol, D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res., 54: 3391-3395, 1994
22. Davis, S T , and Berger, S. H. Variation in human thymidylate synthase is associated with resistance to 5-fluoro-2′-deoxyuridine. Mol Pharmacol., 43: 702-708, 1993.
23. Lenz, H-J., Leichman, C. G., Danenberg, K. D , Danenberg, P. V., Groshen, S., Cohen, H., Laine, L., Crookes, P., Silberman, H., Baranda, J., Garcia, Y., Li, J., and Leichman, L. Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. J. Clin. Oncol., 14: 176-182, 1996
24. Peters, G. J., van der Wilt, C. L., van Groeningen, C. J., Smid, K., Meijer, S., and Pinedo, H M. Thymidylate synthase inhibition after administration of fluorouracil with or without leucovorin in colon cancer patients: implications for treatment with fluorouracil. J. Clin. Oncol., 12: 2035-2042, 1994.